SPRINT: A Smarter Approach to Early-Phase Development

How do you accelerate early-phase drug development without compromising scientific rigor, quality, or safety?
That's the question behind SPRINT, CARBOGEN AMCIS' approach to advancing customer programs through focused decision-making, close collaboration, and phase-appropriate development strategies. In this video interview, our experts Martin Althaus and Marc Lanz explain how SPRINT helps teams move smarter, not just faster.

 
Find out more here: https://www.carbogen-amcis.com/clinical-api-development-manufacturing-services#sprint